| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Dillione Janet | Director | C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS | /s/ Janet Dillione | 2025-11-26 | 0001489798 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Common Stock | Options Exercise | $22.8K | +8K | +16.5% | $2.85 | 56.5K | Nov 24, 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $31.4K | +7.79K | +13.79% | $4.03 | 64.3K | Nov 24, 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $21.6K | +4.88K | +7.59% | $4.43 | 69.1K | Nov 24, 2025 | Direct | |
| transaction | CRMD | Common Stock | Options Exercise | $20.2K | +5.68K | +8.21% | $3.55 | 74.8K | Nov 24, 2025 | Direct | |
| transaction | CRMD | Common Stock | Sale | -$262K | -26.3K | -35.21% | $9.93 | 48.5K | Nov 24, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -8K | -100% | $0.00 | 0 | Nov 24, 2025 | Common Stock | 8K | $2.85 | Direct | F2 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -7.79K | -38.95% | $0.00 | 12.2K | Nov 24, 2025 | Common Stock | 7.79K | $4.03 | Direct | F3 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -4.88K | -24.38% | $0.00 | 15.1K | Nov 24, 2025 | Common Stock | 4.88K | $4.43 | Direct | F4 |
| transaction | CRMD | Stock Option (Right to Buy Common Stock) | Options Exercise | $0 | -5.68K | -18.92% | $0.00 | 24.3K | Nov 24, 2025 | Common Stock | 5.68K | $3.55 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $9.72 to $10.00, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F2 | These options were granted on 02/16/2018. These options are fully vested. |
| F3 | These options were granted on 02/22/2022. These options are fully vested. |
| F4 | These options were granted on 01/14/2023. These options are fully vested. |
| F5 | These options were granted on 03/05/2024. These options are fully vested. |